immune system
• macrophages treated with formyl-Met-Leu-Phe (fMLP) or serum amyloid protein A (SAA) exhibit reduced chemotaxis compared with similarly treated wild-type cells
|
• the ability of AnxA1, dexamethasone, peptide Ac2-26, LXA4, and Cpd43 to inhibit polymorphonuclear accumulation into murine dorsal air pouches inflamed with IL1b is reduced compared to in similarly treated wild-type mice
• AnxA1 fails to inhibit polymorphonuclear accumulation in the peritoneal fluid of mice treated with zymosan unlike in wild-type mice
• SAA fails to increase the number of cells recruited by IL1b compared to in similarly treated wild-type mice
|
• the K/B x N serum provoked artherogenic response is exacerbated and prolonged compared to in similarly treated wild-type mice
|
• carrageenan induces a 2.5-fold increase in paw swelling with a larger number of infiltrating leukocyte compared to in similarly treated wild-type mice
|
homeostasis/metabolism
• following mesenteric ischemic-reperfusion injury, cell migration is increased compared to in similarly treated wild-type mice
• following mesenteric ischemic-reperfusion injury with longer reperfusion times, adherent and emigrated cells are increased compared to in similarly treated wild-type mice
|
skeleton
• the K/B x N serum provoked artherogenic response is exacerbated and prolonged compared to in similarly treated wild-type mice
|
cellular
• macrophages treated with formyl-Met-Leu-Phe (fMLP) or serum amyloid protein A (SAA) exhibit reduced chemotaxis compared with similarly treated wild-type cells
|
hematopoietic system
• macrophages treated with formyl-Met-Leu-Phe (fMLP) or serum amyloid protein A (SAA) exhibit reduced chemotaxis compared with similarly treated wild-type cells
|
• the ability of AnxA1, dexamethasone, peptide Ac2-26, LXA4, and Cpd43 to inhibit polymorphonuclear accumulation into murine dorsal air pouches inflamed with IL1b is reduced compared to in similarly treated wild-type mice
• AnxA1 fails to inhibit polymorphonuclear accumulation in the peritoneal fluid of mice treated with zymosan unlike in wild-type mice
• SAA fails to increase the number of cells recruited by IL1b compared to in similarly treated wild-type mice
|